Our latest Nature Immunology article has been just released

October 21, 2021
No items found.

In the Perspective work-issued today, we highlight the possible genetic background of COVID-19 interindividual variability, ranging from asymptomatic infection to life-threatening disease.

Despite many international efforts, the genetic and immunological determinants of resistance to SARS-CoV-2 infection remain unknown. Following such discoveries like autosomal recessive deficiency of chemokine receptor 5 (CCR5) shown to underlie resistance to HIV-1, we propose a strategy for identifying, recruiting, and genetically analysing individuals who are naturally resistant to SARS-CoV-2 infection. Thus, we’re glad we can contribute to the cohort by submitting several hundred WGS from Polish volunteers and conjointly search for the genetic background of COVID-19 susceptibility/resistance!

Our latest Nature Immunology article has been just released
June 9, 2022

You may also like

Professor Wojciech Niedzwiedz is joining our Scientific Advisory Board

Professor Wojciech Niedzwiedz from the Institute of Cancer Research and one of the top leaders in the field, is joining our Scientific Advisory Board.

MNM at the ESMO 2022 Congress

At ESMO 2022 Congress in Paris the era of AI deployment continues.

Alliance Visionary Leaders “Future of Health & Healthcare” Roundtable

Since our world is changing rapidly, especially biotech and healthcare fields must actively adapt to those alterations. We can all learn from leaders in other industries to understand how our organizations and lives may be changed in the following years.

MNM's platform ARETE works!

MNM's platform ARETE - a proprietary AI technology designed for cancer genomics has been successfully externally validated by one of our Partners.